Welcome

Hematology Franchise Overview

Review of Key Clinical Data Presented at ASH

Q&A

Karl Mahler, Head of Investor Relations and Roche Group Planning

Thomas Fuchs, Vice President, Hematology Franchise Head, Global Product Strategy

Ginna Laport, Vice President & Global Head of Hematology NHL/CLL Marion Ott, M.D., PhD - Global Franchise Head AML, Multiple Myeloma and Pediatric Development